Middle East and Africa Autoinjectors Market Size, Share & Trends Analysis Report By Product Type (Disposable Autoinjectors, Reusable Autoinjectors), By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies), By End Use (Homecare Settings, Hospitals & Clinics, Ambulatory Surgical Centers) and By Country (UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Rest of MEA) Forecasts, 2026-2034

Last Updated: September 01, 2026 | Author: Debashree Bora | Format:

Middle East and Africa Autoinjectors Market Size

The Middle East and Africa Autoinjectors Market size was valued at USD 812 million in 2025 and is projected to grow from USD 881.99 million in 2026 to reach USD 1709.01 million by 2034, growing at a CAGR of 8.62% during the forecast period 2026–2034.

Autoinjectors are pre-filled syringes with needles held in place by a spring. When a sliding motion is used to inject the device into the body, it turns on and gives a measured dose of medicine. Autoinjectors are used to give yourself epinephrine to avoid anaphylaxis or to quickly relieve pain from a migraine, as well as for medical and emergency treatments. Autoinjectors have several benefits, such as making people less afraid of needles, lowering the chance that a needle will get stuck, keeping the dose quality consistent, and helping people be more successful.

Market Key Takeaways

Global Market Size & Growth

Anaphylaxis dominates the market by therapy.

Disposable dominates the market by type.

Homecare dominates the market by end-user.

Middle East and Africa Autoinjectors Market Size

Download a Free Sample To learn more about this report.

Segmental Analysis

The Middle East and Africa Autoinjectors market is segmented based on therapy, type, end-user, and country.

The market is further segmented by therapy into Anaphylaxis, Rheumatoid Arthritis, Psoriasis, migraines, Cardiovascular-diseases, and others.

The Anaphylaxis segment dominates the market and is expected to grow at a CAGR of 9.5% during the forecast period.

Middle East and Africa Autoinjectors Market Size By Segments

Request Customizationto receive a tailored report.

The market is further segmented by type into Disposable, Reusable.

Disposable dominated the market and is expected to register a CAGR of 9.7% over the forecast period.

The market is further segmented by end-user into Hospitals and clinics, home care, and others.

The home care segment dominates the market and is expected to grow at a CAGR of 10.9% during the forecast period.

Middle East and Africa Autoinjectors Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

The Middle East and Africa Autoinjectors market is analyzed by country in the UAE, South Africa, Saudi Arabia, and the Rest of the Middle East and Africa. The rest of the Middle East and Africa dominated the market and is expected to grow at a CAGR of 9.9% during the forecast period.

The Middle East and Africa had the lowest Autoinjectors market share due to weak healthcare infrastructure, notably in Africa. Demographics drive Middle East and Africa autoinjector sales. Population dynamics are increasing and aging. For instance, Africa is expected to become the 2nd most populous continent in ten years, and the Middle East's population growth rate has been around 2% for a decade. The region's average lifespan is 73 years, comparable to many wealthy nations. Lifestyle changes have increased non-contagious chronic diseases and disorders, which will increase autoinjector demand.

This region's rising rates of anaphylaxis and food allergies drive the worldwide autoinjectors market. Autoinjectors will be in great demand due to the increased prevalence of diabetes, asthma, cardiovascular diseases, arthritis, etc. Adrenaline and epinephrine autoinjectors are in high demand due to rising anaphylaxis rates. The tendency toward self-treatment boosts autoinjector growth. Infectious illnesses and Hospital-Acquired Infections (HAIs) are expected to drive market growth and needle stick injury prevention using autoinjectors.

However, difficult economic conditions, a shortage of competent healthcare professionals and nurses with autoinjector expertise, and an underdeveloped healthcare infrastructure hinder regional market growth. According to an NCBI study, Africa lacks epinephrine autoinjectors for outpatients at risk of anaphylaxis.

However, significant market players can build businesses and launch new, cost-effective autoinjector devices in this region. Autoinjector manufacturing improvements and medical device and pharma sector growth are projected to drive the business. Demand is expected to rise due to the Middle East and Africa's aging population. Government activities will support regional market growth to raise awareness of the benefits of self-injection. Foreign nations build manufacturing operations in the Middle East and Africa due to cheap labor and lax regulations. This market's main players can expand into the Middle East and Africa and launch affordable autoinjectors to boost demand.

List of Key and Emerging Players in Middle East and Africa Autoinjectors Market

Pfizer Inc. (Meridian Medical Technologies, Inc.)

Sanofi

Becton, Dickinson, and Company

Key Industry Developments

March 2026

Owen Mumford Pharmaceutical Services expanded its autoinjector platform through new strategic pharmaceutical collaborations focused on combination products and advanced self-injection systems. The initiative supports the increasing adoption of self-administered therapies across the Middle East and Africa.

November 2025

BD (Becton, Dickinson and Company) expanded its self-injection solutions portfolio by introducing enhanced autoinjector technologies designed to improve usability, patient adherence, and compatibility with high-viscosity biologic formulations. The launch strengthens its drug delivery offerings for regional healthcare providers.

August 2025

Ypsomed expanded collaborations with pharmaceutical companies to support the commercialization of next-generation reusable and disposable autoinjector platforms for biologics and self-administered therapies. The initiative enhances access to advanced drug delivery technologies across emerging markets, including the Middle East and Africa.

May 2025

SHL Medical expanded global manufacturing capacity with the opening of its advanced autoinjector production facility in the United States, strengthening supply for pharmaceutical partners serving international markets, including the Middle East and Africa. The expansion supports growing demand for biologic drug delivery devices.

Report Scope

Segmentation

By Product Type 2

Disposable Autoinjectors
Reusable Autoinjectors

By Indication 5

Rheumatoid Arthritis
Multiple Sclerosis
Diabetes
Anaphylaxis
Other Therapies

By End Use 3

Homecare Settings
Hospitals & Clinics
Ambulatory Surgical Centers

Competitive Coverage Pfizer Inc. (Meridian Medical Technologies, Inc.) · Sanofi · Becton, Dickinson, and Company

Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

Pressing the need for patient convenience is the growth factor for the market.

The disposable market sector is expected to dominate over the forecast period.

The Middle East and Africa market growing at a CAGR of 8.62% from (2026–2034).

Pfizer Inc, Sanofi, Becton Dickinson and Company are the prominent players in the market.

About the Author

Debashree Bora

Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.